For example, the expression level of miR-145 in infiltrative-type GC is significantly lower than that in expanding-type GC, and miR-145 can inhibit the migration and invasion of GC cells by targeting FSCN1 (fascin actin-bundling protein 1).12 This evidence concerns the gene FSCN1 and gastric cancer.